Use of Antipsychotic Long-acting Injection in Ekbom Syndrome: A Case of Delusional Parasitosis

被引:0
|
作者
Cicekci, Elvan [1 ]
Orum, Mehmet Hamdi [1 ]
机构
[1] Kahta State Hosp, Clin Psychiat, Adiyaman, Turkey
来源
BEZMIALEM SCIENCE | 2020年 / 8卷 / 03期
关键词
Ekbom syndrome; delusional infestation; delusional parasitosis; delusional disorder; antipsychotic long-acting injection;
D O I
10.14235/bas.galenos.2020.3589
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Ekbom syndrome is the clinical term for delusional parasitosis and is characterized by the patient's fixed and false conviction of being infested with parasites without any objective evidence. Patients with Ekbom syndrome often consult dermatologists, however, sometimes they might try to heal themselves by "removing" the parasites, which may lead to a skin-picking disorder or excoriation. The patient's obsessive treatment of such skin lesions ultimately leads to a vicious cycle that further distances them from psychiatry. Patients with poor adherence to psychiatric treatment may become chronic if left untreated. Although the benefit of antipsychotics in Ekbom syndrome is well-known, a chronic patient who has insufficient social support is not expected to comply with oral therapy. Antipsychotic long-acting injection should be considered as an option for such patients. In this case report, we present a male patient with delusional disorder who showed a symptomatic improvement after being treated with antipsychotic long-acting injection.
引用
收藏
页码:318 / 320
页数:3
相关论文
共 50 条
  • [41] Who receives long-acting antipsychotic medications?
    Glazer, William M.
    PSYCHIATRIC SERVICES, 2007, 58 (04) : 437 - 437
  • [42] Historical perspective on antipsychotic long-acting injections
    Johnson, D. A. W.
    BRITISH JOURNAL OF PSYCHIATRY, 2009, 195 : S7 - S12
  • [43] Safety of the first long-acting atypical antipsychotic
    Llorca, PM
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S99 - S99
  • [44] Long-Acting Antipsychotic Medication and the Outcome of Schizophrenia
    David, Anthony S.
    Gibbs, Ayana
    Patel, Maxine X.
    ADVANCES IN SCHIZOPHRENIA RESEARCH 2009, 2010, : 403 - +
  • [45] PENFLURIDOL - LONG-ACTING ORAL ANTIPSYCHOTIC DRUG
    CLAGHORN, JL
    MATHEW, RJ
    MIRABI, M
    JOURNAL OF CLINICAL PSYCHIATRY, 1979, 40 (02) : 107 - 109
  • [46] Update: Post-injection syndrome observed with olanzapine long-acting injection
    Detke, H.
    Mcdonnell, D.
    Brunner, E.
    Watson, S.
    Kothare, P.
    Treuer, T.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 244 - 244
  • [47] Long-acting, injectable risperidone - the first long-acting, atypical antipsychotic - improves quality of life
    Nasrallah, H
    Duchesne, I
    Mehnert, A
    Janagap, C
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S282 - S282
  • [48] The use of carbamazepine to expedite the metabolism of a long-acting aripiprazole injection
    Socco, Samantha
    Jhawar, Archana
    Riddle, Michael A.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2022, 47 (04) : 562 - 566
  • [49] Long-acting risperidone injection reduces healthcare resource use
    Hagström, P
    Mehnert, A
    Leal, A
    Gefvert, O
    NORDIC JOURNAL OF PSYCHIATRY, 2003, 57 (02) : 98 - 98
  • [50] Impact of risperidone long-acting injection versus oral antipsychotic treatments on hospitalization in schizophrenia
    Olivares, J. M.
    Rodriguez-Morales, A.
    Diels, J. K.
    Povey, M.
    Lam, A.
    Jacobs, A.
    Zhao, Z.
    VALUE IN HEALTH, 2008, 11 (03) : A121 - A122